You are here: Home » PTI Stories » National » News
Business Standard

Aurobindo Pharma CEO Arvind Vasudeva resigns

Press Trust of India  |  New Delhi 

Drug firm Aurobindo Pharma today said its Chief Executive Officer (Formulations) Arvind Vasudeva has resigned from the company.

"Arvind Vasudeva, Chief Executive Officer (Formulations), has resigned from the services of the company to pursue his professional interests with effect from the close of business hours on June 30, 2015," Aurobindo Pharma said in a filing to the BSE.

Recently, the drug firm had said that it intends to invest up to Rs 900 crore this fiscal on various activities including capacity expansion, clinical trials and product filings.

The company has presence in semi-synthetic penicillins and other key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins among others.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, July 01 2015. 17:13 IST